论文部分内容阅读
目的观察和肝饮联合凯西莱治疗非酒精性脂肪肝(NAFLD)的临床疗效。方法将66例NAFLD符合痰瘀互结证者随机分为两组。治疗组36例,采用和肝饮联合凯西莱治疗;对照组30例,采用凯西莱治疗。2月为1疗程,观察6个月。结果治疗组显效18例,有效13例,无效5例,总有效率86.11%;对照组显效6例,有效9例,无效15例,总有效率50.00%。2组患者的总有效率比较,差异有非常显著性意义(P<0.01)。结论和肝饮联合凯西莱治疗非酒精性脂肪肝疗效较好。
Objective To observe the clinical efficacy of Hegan Decoction combined with Kesilai in the treatment of non-alcoholic fatty liver disease (NAFLD). Methods Sixty-six patients with NAFLD who met the criteria of phlegm and blood stasis were randomly divided into two groups. The treatment group of 36 cases, with the combination of liver drink Kesilai treatment; control group of 30 patients treated with Kesilai. February for a course of treatment, observation of 6 months. Results In the treatment group, 18 cases were markedly effective, 13 cases were effective, 5 cases were ineffective and the total effective rate was 86.11%. In the control group, 6 cases were markedly effective, 9 effective and 15 ineffective, with a total effective rate of 50.00%. The total effective rate of two groups of patients, the difference was significant (P <0.01). Conclusions Hexi drink combined with Cisilanes treatment of non-alcoholic fatty liver better.